Arkolith/Insider Trading/ADXS/Form 4/A

Israel Biotech Fund GP Partners II, L.P.

10% OwnerAyala Pharmaceuticals, Inc. (ADXS) · full profile →Form 4/A · filed Sep 29, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 1, 2023Buy(P)0$500000.00$0435K
Sep 1, 2023Buy(P)0$1500000.00$01.3M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001178913-23-003253) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML